Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
de la Harpe KM, Kondiah PPD, Choonara YE, Marimuthu T, du Toit LC, Pillay V
N Engl J Med 373(23):22472257 Muskiet MHA, Tonneijck L, Huang Y, Liu M, Saremi A, Heerspink HJL et al (2018) Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
Its acetylated form also supports cognitive health by facilitating neurotransmitter synthesis and protecting brain cells from oxidative damage
Medical disclaimer This article is for educational information only
Li J, Lv YG, Pan LH, Yao FF, Peng T, Tan YJ, et al
10.1056/NEJMoa1506930 218 KhanH.UllahH.MartorellM.ValdesS
US$ 22.04
US$ 27.93
US$ 21.21
US$ 23.22
US$ 27.48
US$ 29.73
US$ 22.73
